Within the framework of the Flow Cytometry Network, we will participate in the 3 proposed studies, i.e. (1) To identify optimal methodology and interinstitutional procedures; (2) To share in the development and comparison of cell preparation techniques, flow cytometric analysis, data acquisition, interpretation and evaluation, and (3) to develop optimal techniques for analysis of voided urine specimens. Prior extensive histologic and cytologic studies of bladder cancer, as well as flow cytometric data on DNA distribution, strongly suggest that there are 2 distinct, although overlapping pathways of bladder neoplasia: the relatively innocuous papillary, mainly diploid, low grade tumors, and the flat carcinoma in situ (and high grade papillary tumors derived therefrom) which are aneuploid and have an ominous prognosis. It was also suggested that the proportion of tumor cells in S-phase may be of prognostic value. We further documented that the density of nuclear pores and expression of Ca antigen were significantly lower in diploid than in aneuploid tumors, several of which were invasive. Thus, we propose the following specific goals to be pursued: 1. To confirm that the assessment of tumor ploidy and the proportion of cells in S-phase in bladder washings are of diagnostic and prognostic value in bladder tumors. 2. To establish the reliability of flow cytometric data from bladder washings by comparison with DNA content of tissues from bladder tumors and with conventional cytologic and histologic observations in the same patients. 3. To determine the value of flow cytometric data as a replacement for cystoscopy in follow-up of patients with surgically treated tumors. 4. To determine the value of flow cytometry in monitoring of patients undergoing chemo- and immunotherapy (for example, with BCG). 5. To seek methods of processing of voided urine for flow cytometry for purposes of non-invasive and cost-effective monitoring of patients with bladder tumors and as a system of bladder cancer detection. 6. To evaluate new probes and procedures for flow cytometry for bladder tumors. The two overriding goals of these studies are: To seek objective uniform parameters leading to better evaluation, hence optimal treatment and follow-up of patients with bladder tumors and to provide a cost-effective, non-invasive laboratory procedure for bladder cancer diagnosis and detection.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project--Cooperative Agreements (U01)
Project #
3U01CA041025-03S1
Application #
3548769
Study Section
(SRC)
Project Start
1985-09-30
Project End
1989-09-30
Budget Start
1987-09-01
Budget End
1989-09-30
Support Year
3
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Montefiore Medical Center (Bronx, NY)
Department
Type
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10467
Czerniak, B; Cohen, G L; Etkind, P et al. (1992) Concurrent mutations of coding and regulatory sequences of the Ha-ras gene in urinary bladder carcinomas. Hum Pathol 23:1199-204
Koss, L G; Czerniak, B (1992) Image analysis and flow cytometry of tumors of prostate and bladder;with a comment on molecular biology of urothelial tumors. Monogr Pathol :112-28
Wheeless, L L; Coon, J S; Cox, C et al. (1991) Precision of DNA flow cytometry in inter-institutional analyses. Cytometry 12:405-12
Agarwal, V; Greenebaum, E; Wersto, R et al. (1991) DNA ploidy of spindle cell soft-tissue tumors and its relationship to histology and clinical outcome. Arch Pathol Lab Med 115:558-62
Czerniak, B; Deitch, D; Simmons, H et al. (1990) Ha-ras gene codon 12 mutation and DNA ploidy in urinary bladder carcinoma. Br J Cancer 62:762-3
Coon, J S; Deitch, A D; de Vere White, R W et al. (1989) Check samples for laboratory self-assessment in DNA flow cytometry. The National Cancer Institute's Flow Cytometry Network experience. Cancer 63:1592-9
Czerniak, B; Darzynkiewicz, Z; Herz, F et al. (1989) Flow cytometry in clinical oncology: cell cycle and DNA ploidy in assessing tumor behavior. Mater Med Pol 21:3-9
Wheeless, L L; Coon, J S; Cox, C et al. (1989) Measurement variability in DNA flow cytometry of replicate samples. Cytometry 10:731-8
Czerniak, B; Herz, F; Gorczyca, W et al. (1989) Expression of ras oncogene p21 protein in early gastric carcinoma and adjacent gastric epithelia. Cancer 64:1467-73
Koss, L G; Czerniak, B; Herz, F et al. (1989) Flow cytometric measurements of DNA and other cell components in human tumors: a critical appraisal. Hum Pathol 20:528-48

Showing the most recent 10 out of 16 publications